Efficacy and safety of JR-051, a biosimilar of agalsidase beta, in patients with Fabry disease; results of a multicenter, open-label phase 3 study in Japan
Kobayashi, Minako, Yamamoto, Tatsuyoshi, Yamaoka, Mariko, Tomio, TeijiVolume:
123
Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2017.12.201
Date:
February, 2018
File:
PDF, 51 KB
english, 2018